UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
CARDIAC PATHWAYS CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
0141408104
-----------------------------------------------------
(CUSIP Number)
December 31, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 6 Pages
<PAGE>
- ------------------------
CUSIP No. 0141408104
- ------------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Van Wagoner Capital Management, Inc. - 94-3235240
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)[ ]
(b)[X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
-0-
SHARES --------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
-0-
OWNED BY --------------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
1,168,500(1)
REPORTING --------------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON
-0-
WITH
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,168,500(1)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
Not Applicable
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
38.8%(1)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA
================================================================================
- -----------------
(1) Represents 1,000,000 shares of Common Stock issuable upon conversion of
Series B Preferred Stock and 168,500 shares of Common Stock (with the
percent ownership calculated based upon an aggregate of 2,007,904 shares
outstanding as of November 12, 1999, and assuming the conversion of the
Series B Preferred Stock owned by the reporting person).
Page 2 of 6 Pages
<PAGE>
- ------------------------
CUSIP No. 0141408104
- ------------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Van Wagoner Funds, Inc. - 39-1836333, 39-1836332, 94-3256424,
94-3286386
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)[ ]
(b)[X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Maryland
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
1,000,000(1)
SHARES --------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
-0-
OWNED BY --------------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
-0-
REPORTING --------------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON
-0-
WITH
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,000,000(1)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
Not Applicable
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
33.2%(1)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IV
================================================================================
- -----------------
(1) Represents 1,000,000 shares of Common Stock issuable upon conversion of
Series B Preferred Stock with the percent ownership calculated based upon
an aggregate of 2,007,904 shares outstanding as of November 12, 1999, and
assuming the conversion of the Series B Preferred Stock owned by the
reporting person).
Page 3 of 6 Pages
<PAGE>
- ------------------------
CUSIP No. 0141408104
- ------------------------
This Amendment No. 1 to the undersigned's Schedule 13G, which was
originally filed on August 9, 1999 (the "Schedule 13G") with regard to Cardiac
Pathways Corporation (the "Issuer") is being filed to amend Item 4 of the
Schedule 13G. Except as expressly stated herein, there have been no material
changes in the information set forth in the Schedule 13G.
Item 4. Ownership
------- ---------
Van Wagoner Capital Management, Inc.
-----------------------------------
(a) Amount Beneficially Owned: 1,168,500*
(b) Percent of Class: 38.8%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: -0-
(ii) shared power to vote or to direct the vote: -0-
(iii)sole power to dispose or to direct the disposition of:
1,168,500
(iv) shared power to dispose or to direct the disposition
of: -0-
Van Wagoner Funds, Inc.
----------------------
(a) Amount Beneficially Owned: 1,000,000*
(b) Percent of Class: 33.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 1,000,000
(ii) shared power to vote or to direct the vote: -0-
(iii)sole power to dispose or to direct the disposition of:
-0-
(iv) shared power to dispose or to direct the disposition
of: -0-
- ---------------
* Van Wagoner Capital Management, Inc. and Van Wagoner Funds, Inc. share
beneficial ownership over the same 1,000,000 shares.
Page 4 of 6 Pages
<PAGE>
- ------------------------
CUSIP No. 0141408104
- ------------------------
Exhibits.
--------
1. Agreement to file Schedule 13G jointly.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 2000
- -------------------------
Date
VAN WAGONER CAPITAL MANAGEMENT, INC.
By:/s/ Garrett R. Van Wagoner
-----------------------------------------
Garrett R. Van Wagoner, President
VAN WAGONER FUNDS, INC.
By:/s/ Garrett R. Van Wagoner
-----------------------------------------
Garrett R. Van Wagoner, President
Page 5 of 6 Pages
- ------------------------
CUSIP No. 0141408104
- ------------------------
EXHIBIT 1
---------
AGREEMENT, dated as of February 11, 2000, by and among Van Wagoner
Capital Management, Inc., a Delaware corporation and Van Wagoner Funds, Inc., a
Maryland corporation.
WHEREAS, in accordance with Rule 13d-1(k) of the Securities Exchange
Act of 1934 (the "Act"), only one such statement need be filed whenever two or
more persons are required to file a statement pursuant to Section 13(d) of the
Act with respect to the same securities, provided that said persons agree in
writing that such statement is filed on behalf of each of them.
NOW, THEREFORE, in consideration of the premises and mutual agreements
herein contained, the parties hereto agree as follows:
Both Van Wagoner Capital Management, Inc. and Van Wagoner Funds, Inc.
hereby agree, in accordance with Rule 13d-1(k) under the Act, to file one
Statement on Schedule 13G relating to their ownership of the Common Stock of
Cardiac Pathways Corporation, and hereby further agree that said Statement shall
be filed on behalf of both Van Wagoner Capital Management, Inc. and Van Wagoner
Funds, Inc. Nothing herein shall be deemed to be an admission that the parties
hereto, or any of them, are members of a "group" (within the meaning of Section
13(d) of the Act and the rules promulgated thereunder) with respect to any
securities of Cardiac Pathways Corporation.
IN WITNESS WHEREOF, the parties have executed this agreement as of the
date first written above.
VAN WAGONER CAPITAL MANAGEMENT, INC.
By: /s/ Garrett R. Van Wagoner
----------------------------------
Garrett R. Van Wagoner, President
VAN WAGONER FUNDS, INC.
By: /s/ Garrett R. Van Wagoner
----------------------------------
Garrett R. Van Wagoner, President
Page 6 of 6 Pages
